Boosting Tumor Accumulation of Phthalocyanine through Sialylation Engineering for Superior Cancer Phototherapy
Advanced Healthcare Materials · 2025-01 · 14 (1)
DOI: 10.1002/adhm.202402381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 18.11.2024. Verfasst von Jian Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. Hauptthemen laut MEDLINE: Indoles, Isoindoles, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Phthalocyanines (Pcs) are widely developed in cancer phototherapy due to their definite chemical structure and tunable photosensitivity. However, their in vivo application is hampered by low water solubility and non‐specific biodistribution. Here,a strategy of sialylation‐modulation is developed for the first time to highly improve the bioavailability of Pcs. The sialylated Pcs (ZnPc‐4SA) not only has good hydrophilicity, but also can self‐assemble into nanoparticles (ZnPc‐4SA NPs). These nanoformulations retain the excellent photophysical properties of Pcs, which in turn reflects excellent optoacoustic and phototherapeutic properties. Importantly, ZnPc‐4SA NPs exhibit boosted tumor accumulation due to the passive targeting and sialic acid‐mediated E‐selectin targeting. Besides, the phototoxicity of ZnPc‐4SA NPs can effectively trigger cell apoptosis and tumor elimination upon laser irradiation. Therefore, sialylation engineering strategy provides a new option for hydrophobic drugs modification with enhanced tumor theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
- Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, 310027, China.
ORCID-Profile: Nian Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- Medical and Health Research Project of Zhejiang Province
Zitieren
APA
Li, J., Wang, T., Li, C., Zhang, X., Li, J., Zhang, D., Zhang, Y., Yang, J., Su, X., & Liu, N. (2025). Boosting Tumor Accumulation of Phthalocyanine through Sialylation Engineering for Superior Cancer Phototherapy. Advanced Healthcare Materials, 14(1). https://doi.org/10.1002/adhm.202402381
Vancouver
Li J, Wang T, Li C, Zhang X, Li J, Zhang D, et al. Boosting Tumor Accumulation of Phthalocyanine through Sialylation Engineering for Superior Cancer Phototherapy. Advanced Healthcare Materials. 2025;14(1). doi:10.1002/adhm.202402381
BibTeX
@article{Li2025,
author = {Li, Jian and Wang, Tingting and Li, Cijuan and Zhang, Xun and Li, Jingchao and Zhang, Dongsheng and Zhang, Yafei and Yang, Jun and Su, Xinhui and Liu, Nian},
title = {Boosting Tumor Accumulation of Phthalocyanine through Sialylation Engineering for Superior Cancer Phototherapy},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {1},
doi = {10.1002/adhm.202402381}
}
EUVIMED